FOLH1 and neoplasm: PSMA (Prostate-specific membrane antigen), also known as glutamate carboxypeptidase II, is a type 2 transmembrane glycoprotein that is overexpressed in prostate adenocarcinomas [12] and highly expressed in the endothelium of tumor-associated neovasculature [13].